Instem plc Investor Teach-in
March 09 2017 - 1:01AM
RNS Non-Regulatory
TIDMINS
Instem plc
09 March 2017
Instem plc
("Instem")
Investor Teach-in
Instem plc (AIM: INS), a leading provider of IT solutions to the
global early development healthcare market, announces it will be
holding a teach-in for investors and analysts on Tuesday, 28th
March 2017.
The event will be held in the Black Bar, upstairs at Rocket Bar,
6 Adams Court, Old Broad Street, London EC2N 1DX from 5pm for a
5.15pm start.
A presentation will be given by the Instem management team, CEO,
Phil Reason, and CFO, Nigel Goldsmith, for approximately 45
minutes, at which point there will be an opportunity for questions.
The presentation will include an overview of the Company and an
outline of their strategy to deliver value for shareholders. No new
material financial information will be disclosed. This will be
followed by light refreshments and an opportunity to network.
To register for the event, please email instem@walbrookpr.com or
call the Walbrook PR team below.
For further information, please contact:
Instem plc Tel: +44 (0) 1785 825
600
Phil Reason, CEO www.instem.com
Nigel Goldsmith, CFO
N+1 Singer (Nominated Tel: +44 (0) 20 7496 3000
Adviser & Broker)
Richard Lindley
Nick Owen
James White
Walbrook PR Ltd Tel: +44 (0) 20 7933 8780
or
Paul Cornelius instem@walbrookpr.com
Sam Allen
Helen Cresswell
Paul Whittington
About Instem
Instem is a leading supplier of IT applications and services to
the early development healthcare market delivering compelling
solutions for data collection, analysis and regulatory submissions
management. Instem solutions are in use by customers worldwide,
meeting the rapidly expanding needs of life science and healthcare
organisations for data-driven decision making leading to safer,
more effective products.
Instem's portfolio of software solutions increases client
productivity by automating study-related processes while offering
the unique ability to generate new knowledge through the extraction
and harmonisation of actionable scientific information. Instem
supports over 500 clients through offices in the United States,
United Kingdom, France, Japan, China and India. To learn more about
Instem solutions and its mission, please visit www.instem.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRADMGGFDRLGNZM
(END) Dow Jones Newswires
March 09, 2017 02:01 ET (07:01 GMT)
Instem (LSE:INS)
Historical Stock Chart
From Apr 2024 to May 2024
Instem (LSE:INS)
Historical Stock Chart
From May 2023 to May 2024